GANX β€” GAIN THERAPEUTICS INC

Ownership history in TWO SIGMA SECURITIES, LLC  Β·  3 quarters on record

This page tracks every 13F SEC filing in which TWO SIGMA SECURITIES, LLC reported a position in GAIN THERAPEUTICS INC (GANX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
0.01% (2025 Q3)
πŸ“Š Avg. % of fund
0.0%
πŸ“… First filed
2022 Q4
πŸ“… Last filed
2025 Q3
⏱ Quarters held
3
% of Fund (quarterly)    GANX price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 3 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 27,323 +12,968 +90.3% 0.01% $48K $1.77
2025 Q1 ADDED 14,355 +1,613 +12.7% 0.00% $27K $1.91
2022 Q4 INITIATED 12,742 β€” β€” 0.00% $40K β€”

🏒 Other funds also holding GANX

As of 2025 Q4 β€” sorted by position size

DME Capital Management, LP 0.06% BENEDICT FINANCIAL ADVISORS INC 3Y 7Y 0.03% Oliver Luxxe Assets LLC 3Y 7Y 0.01% PRELUDE CAPITAL MANAGEMENT, LLC 3Y 7Y 0.01% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.01% MARSHALL WACE, LLP 3Y 7Y 0.0% Cambridge Investment Research Advisors, Inc. 3Y 7Y 0.0% Sandhill Capital Partners LLC 3Y 7Y 0.0% Lighthouse Investment Partners, LLC 3Y 0.0% Cresset Asset Management, LLC 3Y 7Y 0.0%
← Back to TWO SIGMA SECURITIES, LLC Holdings